A clinical trial involving 56 patients at the Hadassah Medical Center and Beer Yaakov Mental Health Center reveals that Deep Transcranial Magnetic Stimulation (TMS) is effective and safe for treating depression.

Brainsway Ltd., the owner of TMS, reports that 22 of the 45 patients who completed at least 10 treatments showed statistically significant improvement and 13 patients achieved full recovery. Side effects proved minor, including slight headaches for some patients, mostly during their first treatment.

Brainsway is simultaneously conducting a number of trials using TMS to treat a number of neurological disorders, such as multiple sclerosis and attention deficit disorder(ADD). In addition, TMS is being tested on people struggling with obesity, patients with chronic lung disease who are attempting to stop smoking, as well as those suffering from cocaine addiction. The multiple sclerosis trial is being done at Charité University Hospital in Berlin and the others at medical institutions in the United States.